SEC CIK 1836011
Rayment Kevin
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| CWview stock → | 31,519 | 2026-07-06 |
Position History — CW
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — CW
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-07-06 | Grant / award | 26 | $634.88 | 31,519 |
| 2026-03-17 | Open-market sale | 907 | $677.38 | 31,493 |
| 2026-03-16 | Option exercise (derivative) | 2,504 | $0.00 | 3,928 |
| 2026-03-16 | Option exercise | 2,504 | $0.00 | 32,400 |
| 2026-03-09 | Grant / award (derivative) | 652 | $0.00 | 6,432 |
| 2026-02-04 | Open-market sale | 2,634 | $626.33 | 29,896 |
| 2026-02-03 | Grant / award | 6,618 | $674.32 | 32,530 |
| 2026-01-05 | Grant / award | 10 | $472.17 | 25,912 |
| 2025-07-02 | Grant / award | 39 | $414.23 | 25,902 |
| 2025-03-18 | Open-market sale | 1,003 | $325.73 | 25,863 |
| 2025-03-17 | Option exercise (derivative) | 2,630 | $0.00 | 5,768 |
| 2025-03-17 | Option exercise | 2,630 | $0.00 | 26,866 |
| 2025-03-10 | Grant / award (derivative) | 1,466 | $0.00 | 8,398 |
| 2025-02-05 | Open-market sale | 2,664 | $346.92 | 24,236 |
| 2025-02-04 | Grant / award | 6,934 | $344.57 | 26,900 |
| 2025-01-06 | Open-market buy | 52 | $304.12 | 19,966 |
| 2024-06-03 | Open-market sale | 8,415 | $281.67 | 19,914 |
| 2024-03-19 | Conversion (derivative) | 2,786 | $244.73 | 6,915 |
| 2024-03-19 | Open-market sale | 1,070 | $243.50 | 28,329 |
| 2024-03-19 | Grant / award | 2,786 | $0.00 | 29,399 |
| 2024-03-14 | Grant / award (derivative) | 1,800 | $240.97 | 9,701 |
| 2024-02-08 | Open-market sale | 2,832 | $225.04 | 26,613 |
| 2024-02-08 | Grant / award | 7,322 | $226.88 | 29,445 |
| 2024-02-06 | Option exercise (derivative) | 8,609 | $0.00 | 7,901 |
| 2024-02-06 | Option exercise | 8,609 | $225.95 | 25,458 |
| 2024-02-06 | Open-market sale | 3,335 | $225.53 | 22,123 |
| 2023-03-21 | Conversion (derivative) | 2,750 | $0.00 | 13,728 |
| 2023-03-21 | Open-market sale | 1,055 | $171.00 | 16,849 |
| 2023-03-21 | Conversion | 2,750 | $0.00 | 17,904 |
| 2023-03-17 | Grant / award (derivative) | 2,482 | $0.00 | 16,478 |
| 2023-02-15 | Grant / award | 4,469 | $170.30 | 16,905 |
| 2023-02-15 | Open-market sale | 1,751 | $169.38 | 15,154 |
| 2022-03-17 | Grant / award (derivative) | 2,600 | $0.00 | 16,706 |
| 2022-03-15 | Conversion (derivative) | 1,651 | $0.00 | 14,106 |
| 2022-03-15 | Open-market sale | 711 | $144.63 | 12,436 |
| 2022-03-15 | Conversion | 1,651 | $144.85 | 13,147 |
| 2022-02-16 | Grant / award | 1,797 | $138.03 | 12,219 |
| 2022-02-16 | Open-market sale | 723 | $137.23 | 11,496 |
| 2021-03-31 | — | — | — | 10,422 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.